1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antibiotics Market – By Drug Class
1.3.2 Global Antibiotics Market – By Action Mechanism
1.3.3 Global Antibiotics Market – By Geography
2. Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antibiotics Market – Market Landscape
4.1 Pest Analysis
4.1.1 North America– PEST Analysis
4.1.2 Europe– PEST Analysis
4.1.3 Asia Pacific
4.1.4 Middle East & Africa
4.1.5 South & Central America
5. Antibiotics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Increasing Development of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – Global Analysis
6.1 Global Antibiotics Market Revenue Forecast And Analysis
6.2 Global Antibiotics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antibiotics Market Analysis – By Drug Class
7.1 Overview
7.2 Antibiotics Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 Sulfonamides: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 Aminoglycosides: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Carbapenem
7.5.1 Overview
7.5.2 Carbapenem: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Macrolides
7.6.1 Overview
7.6.2 Macrolides: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 Fluoroquinolones: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Penicillin
7.8.1 Overview
7.8.2 Penicillin: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Cephalosporin
7.9.1 Overview
7.9.2 Cephalosporin: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8. Antibiotics Market – By Action Mechanism
8.1 Overview
8.2 Antibiotics Market, by Action Mechanism, 2019 and 2027 (%)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 Mycolic Acid Inhibitors: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 RNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 DNA Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 Protein Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 Cell Wall Synthesis Inhibitors: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
9. Antibiotics Market – Geographic Analysis
9.1 North America: Antibiotics Market
9.1.1 Overview
9.1.2 North America: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 North America: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 North America: Antibiotics Market, by Country, 2019 & 2027 (%)
9.1.6 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 US: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 Canada: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 Mexico: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2 Europe: Antibiotics Market
9.2.1 Overview
9.2.2 Europe: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.4 Europe: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2.5 Europe: Antibiotics Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.6.3 Germany: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2.7 UK: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.7.3 UK: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2.8 France: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.8.3 France: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2.9 Spain: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.9.3 Spain: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.2.10 Italy: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.2.10.3 Italy: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3 Asia Pacific: Antibiotics Market
9.3.1 Overview
9.3.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3.5 Asia Pacific: Antibiotics Market, by Country, 2018 & 2027 (%)
9.3.6 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.6.3 China: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3.7 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.7.3 Japan: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3.8 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.8.3 India: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3.9 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.3.10 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.3.10.3 Australia: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.4 Middle East & Africa: Antibiotics Market
9.4.1 Overview
9.4.2 Middle East & Africa: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.4.4 Middle East & Africa: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.4.5 Middle East & Africa: Antibiotics Market Share by Country – 2019 & 2027, (%)
9.4.6 Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.4.6.3 Saudi Arabia: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.4.7 UAE: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.4.7.3 UAE: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.4.8 South Africa: Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.4.8.3 South Africa: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.5 South and Central America: Antibiotics Market
9.5.1 Overview
9.5.2 South and Central America: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.5.4 South and Central America: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.5.5 South and Central America: Antibiotics Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.5.6.3 Brazil: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.5.7 Argentina: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.5.7.3 Argentina: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTICS MARKET
10.1 North America: Impact assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
10.4 Rest of World: Impact assessment of COVID-19 Pandemic
11. Antibiotics Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Antibiotics Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bayer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bristol-Myers Squibb Company
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Astellas Pharma Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Abbott
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Eli Lilly and Company.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms